MedCentral

More physicians are questioning whether to stay in practice. Nearly half (44%) of respondents to this year’s MedCentral Evolution of Medical Practice survey said they had considered leaving medical practice since the start of 2026, compared with 35% of respondents in last year’s survey. Physicians point to mounting complex clinical demands, persistent stress, and an aging workforce as reasons they are reconsidering their future in medicine.

Physicians reveal the biggest obstacles in their medical practices and share the changes they’ve made to adapt to an evolving healthcare system.

Introduction In MedCentral’s third annual national survey, The Evolution of Medical Practice, physicians shared how they are adapting to challenges at work, while also managing stress and their personal health. More than 800 US-based physicians responded this year, with nearly half saying they’ve considered leaving medical practice since the start of the year. Meet Drops Hear what life with a health condition actually looks like. Now in one app.

The unveiling of the 2026 AHA/ACC/ADA/ASN Cardiovascular-Kidney-Metabolic (CKM) Syndrome guidelines marks a pivotal moment in our approach to patient care. This comprehensive societal statement is a much-needed catalyst for dialogue and action across three intimately intertwined disease processes. As a nephrologist, I view these guidelines with considerable optimism, particularly as the relentless rise of diabetes and obesity continues to challenge our healthcare systems.

The management of hypertension, a key feature of nephritic syndrome, is crucial to the care of patients with immunoglobin A nephropathy (IgAN).

Even though the ICD-10-CM code set is quite substantial, many clinicians may come up short when seeking very specific diagnosis codes. That may change later this year, when 190 new codes will join the code set, representing such conditions as low body mass index (BMI), plantar fasciitis, cardiomyopathy, sinusitis, and many more. The US Centers for Disease Control and Prevention (CDC) shared the 2027 ICD-10-CM coding updates earlier this month.

Erectile dysfunction (ED) affects 30 to 50 million males in the United States. Prevalence increases with age, affecting about 70% of males by age 70, but ED is not an inevitable consequence of aging. A whole-person approach to treating ED – including increasing recognition as a potential marker of cardiovascular disease – is crucial for optimal management.

The Endocrine Society’s 2026 Conference was held June 13-16 in Chicago. The following are summaries of top highlights from research presented at the meeting. Tirzepatide Stimulates Brown Adipose Tissue Activity Abstract: Herman R, Jensterle M, Lezaic L, et al. Tirzepatide stimulates brown adipose tissue activity independent of weight loss in women with obesity: TABFAT trial. ENDO 2026 Annual Meeting Abstract. Meet Drops Hear what life with a health condition actually looks like. Now in one app.

The American Headache Society (AHS)’s 2026 Scientific Meeting in Orlando held earlier this month highlighted a field that is rapidly evolving beyond the initial wave of calcitonin gene-related peptide-targeted (CGRP) therapies. While CGRP-targeted therapies remain central to migraine management, the dominant theme was no longer whether CGRP works – it clearly does.

Neuromodulation is a rapidly growing field that has become increasingly important in the treatment of chronic pain. There is evidence that, in appropriately selected patients, neuromodulation therapies can decrease pain and improve function in individuals with chronic pain from various sources. Technologies such as spinal cord stimulation, peripheral nerve stimulation, and newer “restorative” muscle stimulation systems are now widely used in civilian and military medicine chronic pain practices.